Board Members

Dr Jack LittleJack E. Little, PhD, Chairman

Dr. Little served as President and Chief Executive Officer of Shell Oil Company, and a member of the Board of Directors and Chairman and Chief Executive Officer of Shell Exploration & Production Company for more than five years until his retirement in June 1999.  With extensive operations in the United States, Shell Oil Company and its subsidiaries explore, develop, produce, purchase, transport, and market crude oil and natural gas.  They also purchase, manufacture, transport, and market oil and chemical products and provide technical and business services. Dr. Little also served as a director of TXU Corporation from 2001 to 2007 and currently serves as a Trustee for the Baylor College of Medicine. Dr. Little brings extensive experience in the energy industry, specifically in oil and gas exploration and production and related services.


 

Thomas C. Thompson

Thomas C. Thompson was formerly Chairman and CEO of Gulf States Oil and Refining Co.  He is a founding member and has served more than 30 years on the Baylor College of Medicine Technologies Board.  Mr. Thompson has served on the board of numerous medical technology companies and has been the managing director of a number of medical technology investment partnerships.  He is currently the Chairman of Thompson Energy Group, LLC, one of the nation’s largest petroleum products brokerage firms, Medical Metrics, Inc., a medical imaging core lab and leading provider of centralized radiographic reading services to the clinical trials industry and Laser Gen, Inc., an innovative research and development company dedicated to the advancement of nucleotide chemistry and sequencing technology.  Mr. Thompson attended The University of Houston and The University of Texas and was honored with a PhD in Business Administration from Nathantial Hawtorn College in Antrim, New Hampshire.


 

Fred LummisFred Lummis, Chairman & CEO of Platform LLC

Fred Lummis co-founded Platform and serves as its Chairman and Chief Executive Officer. Mr. Lummis is responsible for managing all aspects of the investment activities of Platform, including capital raising, investment sourcing, due diligence, and management of portfolio companies. Prior to founding Platform, Mr. Lummis co-founded The CapStreet Group (and its predecessor company, Summit Capital) where he managed its private equity investments. He has significant operational experience, having served as Chief Executive Officer of American Tower Corporation and Advantage Outdoor Company, and as Interim Chief Executive Officer of Cardtronics.

Prior to founding CapStreet, Mr. Lummis was a Senior Vice President of Duncan, Cook & Co. and a Vice President of Texas Commerce Bank, where he managed the bank’s venture capital portfolio. He serves on the Board of Directors of Cardtronics, Landmark FBO, TRE Financial Services, Avalon Advisors and, until recently, American Tower Corporation. Mr. Lummis is active in the Houston community and serves on the board of Baylor College of Medicine and Amegy Bancshares. He received his BA from Vanderbilt University and his MBA from the University of Texas at Austin.  He has three children and is an avid tennis player and baseball fan.


 

Kimberly Cotner DavidKimberly Cotner David

Kimberly Cotner David is the Vice President of Finance and Planning for the Baylor College of Medicine. She is a Certified Public Accountant, with a BS in Accounting from Oklahoma State University and an MBA from Rice University. Prior to joining the College, Ms. Cotner David worked at Arthur Andersen for ten years in a variety of accounting and management positions. In her current position at the Medical School and the new Baylor Clinic and Hospital, Ms. Cotner David’s responsibilities include the Operating and Capital Budget, Financial Reporting, Treasury, Endowment Accounting, Financial Accounting and Disbursements including Payroll and Accounts Payable. She enjoys volunteering and currently serves on the boards of Child Advocates, Inc.; Houston Harris County Immunization Registry; and Shoulder to Shoulder. Additionally, she is a member of the Houston Livestock Show and Rodeo Wine Committee, Houston Ballet Guild, and the Texas Medical Center Women’s Health Network.


 

AKuspaAdam Kuspa, PhD

Dr. Kuspa is Senior Vice President for Research at Baylor College of Medicine. He received his BA in Biochemistry from the University of California at San Diego, his PhD in biochemistry from Stanford University, and he served as an American Cancer Society postdoctoral fellow at the University of California at San Diego. He joined the Baylor College of Medicine faculty in 1993 as an assistant professor of biochemistry and has been involved in several programs, including Developmental Biology and Molecular and Human Genetics, as well as the Human Genome Sequencing Center. Dr. Kuspa was elected a Fellow of the American Association for the Advancement of Science in 2005. He served as chair of the Verna and Marrs McLean Department of Biochemistry from March 2006 to April 2011, and was named to head Baylor College of Medicine’s research enterprise in July 2010. In addition to working at many levels to achieve the college’s strategic vision in research, Dr. Kuspa’s own federally funded laboratory currently investigates how eukaryotic cells kill bacteria.

Dr. Kuspa’s interests include the signaling systems that regulate the development and cell differentiation of the social amoeba Dictyostelium discoideum, and the recognition of bacteria by amoeba. He directed the consortium that completed the first genome sequence of an amoeba, uncovering genes previously thought to be specific to animals or plants. Recently, he discovered an innate immune system in the social amoeba that utilizes protein homologs found in similar systems in plants and animals, suggesting a common evolutionary origin for bacterial recognition by eukaryotes. Collaborative efforts include the development of functional genomic tools, such as the use of global transcriptional profiling for genetic epistasis analyses and the genetic analysis of the evolution of eusociality that has identified numerous pathways involved in the stabilization of cellular cooperation.


 

Robert CorriganRobert Corrigan, Jr.

Mr. Corrigan is currently Senior Vice President, General Counsel, and Corporate Secretary of  Baylor College of Medicine, a nationally-ranked health sciences university located in Houston’s Texas Medical Center.  Prior to joining Baylor, Mr. Corrigan was a partner in the Health Law Section of Fulbright & Jaworski’s Houston office where, for 23 years, he represented medical schools, hospitals, physician, and physician groups in business matters.  While at Fulbright, Mr. Corrigan was recognized as a Texas’ “SuperLawyer” in Health Law many times.  He was also listed in “Best Lawyers in America,” Health Law, from 2001 – 2011, when he resigned his law partnership to join Baylor.  Mr. Corrigan received his undergraduate degree from Rice University and his law degree from Vanderbilt.  Mr. Corrigan is active in community affairs.  He just completed his tenth year of service on the board of directors of Friends of Mental Health Mental Retardation Authority of Harris County, a charity providing support to the indigent population served by MHMRA.  He is also on the board of directors of the American Productivity & Quality Center, a Houston-based tax-exempt think tank.  An association football enthusiast, Mr. Corrigan channels what remains of his spare time to promote the sport, serving on the board of directors of Dynamo Charities, the philanthropic arm of Houston’s professional soccer team and as a director and president of Houston Express Soccer Club, one of Houston’s premier youth sports clubs.